What are the major opportunities in the Diabetes Care Drugs market? What are the strategies for the Diabetes Care Drugs market?

For detailed insights on the major opportunities and strategies in the Diabetes Care Drugs market, Read More

How does the Diabetes Care Drugs market relate to the overall economy and other similar markets?

For detailed insights on Diabetes Care Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Diabetes Care Drugs market growth? SWOT analysis of the Diabetes Care Drugs market.

For detailed insights on the key dynamics influencing the Diabetes Care Drugs market growth and SWOT analysis of the Diabetes Care Drugs industry, Read More

Global Diabetes Care Drugs Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Diabetes Care Drugs Global Market Report 2025

Name: Diabetes Care Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Insulin, Biguanides, Sulfonylureas, Dipeptidyl Peptidase (DPP)-4 Inhibitors, Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, Glucagon-Like Peptide (GLP)-1 Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors), By Formulation Type (Tablets, Injections, Solutions, Gels, Extended-Release Formulations), By Administration Route (Oral, Injectable, Inhalable), By Condition (Diabetes Type 1, Diabetes Type 2), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Diabetes Care Drugs Market Overview

• Diabetes Care Drugs market size has reached to $69.55 billion in 2024

• Expected to grow to $90.50 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: Increasing Number Of Diabetic Patients Fueling The Growth Of The Market Due To Unhealthy Diets And Sedentary Lifestyles

• Market Trend: Dual Action Therapy Controls Fasting And Post Meal Glucose Spikes

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diabetes Care Drugs Market?

Diabetes care drugs are medications used to manage blood glucose levels in individuals with diabetes mellitus, including type 1, Type 2 diabetes, and gestational diabetes. These drugs work by improving insulin production, enhancing insulin sensitivity, or reducing glucose absorption. The main aim of these drugs is to prevent complications by maintaining healthy blood sugar levels.

The main drug classes in diabetes care drugs are insulin, biguanides, sulfonylureas, dipeptidyl peptidase (DPP)-4 inhibitors, sodium-glucose co-transporter (SGLT)-2 inhibitors, glucagon-like peptide (GLP)-1 receptor agonists, thiazolidinediones, and alpha-glucosidase inhibitors. Insulin refers to a pharmaceutical preparation of the hormone insulin, administered via injection or inhalation to compensate for the body's insufficient natural production or utilization. These drugs are available in various formulation types, such as tablets, injections, solutions, gels, and extended-release formulations. They can be administered through oral, injectable, and inhalable routes and are primarily indicated for managing Type 1 and Type 2 diabetes. These drugs are distributed through various channels, including hospital pharmacies and specialty pharmacies.

Diabetes Care Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Diabetes Care Drugs Market Size 2025 And Growth Rate?

The diabetes care drugs market size has grown strongly in recent years. It will grow from $69.55 billion in 2024 to $73.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising global prevalence of diabetes, increasing aging population, sedentary lifestyles and poor dietary habits, rising obesity rates, and growing adoption of personalized medicine.

What Is The Diabetes Care Drugs Market Growth Forecast?

The diabetes care drugs market size is expected to see strong growth in the next few years. It will grow to $90.50 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to emergence of biosimilar insulins, development of combination therapies and fixed-dose formulations, increasing focus on continuous glucose monitoring and closed-loop systems, and rising awareness and prevention programs targeting prediabetes. Major trends in the forecast period include integration of continuous glucose monitoring with smart drug delivery, adoption of digital patient engagement platforms, wearable drug delivery devices, advancement in peptide or polymer-based sustained-release formulations, and integration of pharmacogenomics for personalized dosing.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Diabetes Care Drugs Market Segmented?

1) By Drug Class: Insulin, Biguanides, Sulfonylureas, Dipeptidyl Peptidase (DPP)-4 Inhibitors, Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, Glucagon-Like Peptide (GLP)-1 Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors

2) By Formulation Type: Tablets, Injections, Solutions, Gels, Extended-Release Formulations

3) By Administration Route: Oral, Injectable, Inhalable

4) By Condition: Diabetes Type 1, Diabetes Type 2

5) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies

Subsegments:

1) By Insulin: Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, Long-acting insulin, Pre-mixed insulin

2) By Biguanides: Metformin Immediate Release (IR), Metformin Extended Release (ER)

3) By Sulfonylureas: First-generation sulfonylureas, Second-generation sulfonylureas

4) By Dipeptidyl Peptidase (DPP)-4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

5) By Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin

6) By Glucagon-Like Peptide (GLP)-1 Receptor Agonists: Exenatide, liraglutide, Dulaglutide, Semaglutide, Lixisenatide

7) By Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone

8) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol

What Is Driving The Diabetes Care Drugs Market? Increasing Number Of Diabetic Patients Fueling The Growth Of The Market Due To Unhealthy Diets And Sedentary Lifestyles

The increasing number of diabetic patients is expected to propel the growth of the diabetes care drugs market going forward. Diabetic patients refer to individuals who have been diagnosed with diabetes mellitus, a chronic medical condition that affects how the body processes blood sugar (glucose). The increasing number of diabetic patients is mainly due to unhealthy diets and sedentary lifestyles, as they promote obesity and insulin resistance. Diabetes care drugs help diabetic patients manage blood glucose levels effectively, making them vital for controlling type 1 and type 2 diabetes. They prevent complications by stabilizing sugar levels, improving overall health, and improving quality of life. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing number of diabetic patients is driving the growth of the diabetes care drugs industry.

Who Are The Major Players In The Global Diabetes Care Drugs Market?

Major companies operating in the diabetes care drugs market are Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GSK plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceuticals Limited, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Takeda Pharmaceutical Company Limited, Biocon Limited, Glenmark Pharmaceuticals Limited, Insulet Corporation, Torrent Pharmaceuticals Ltd., Hanmi Pharmaceutical Limited, Hualan Biological, Wockhardt, Mitsubishi Tanabe Pharma, Gan & Lee Pharmaceuticals, DiogenX, Oramed Pharmaceuticals, Apotex.

What Are The Key Trends Of The Global Diabetes Care Drugs Market? Dual Action Therapy Controls Fasting And Post Meal Glucose Spikes

Major companies operating in the diabetes care drugs market are focusing on developing advanced treatments, such as fixed-ratio combination therapies, to improve glycemic control, enhance patient adherence, and simplify treatment regimens. Fixed-ratio combination therapies refer to medications that combine two complementary antidiabetic agents in a single injection, offering a more convenient and effective approach to managing diabetes. For instance, in April 2024, Sanofi SA, a France-based pharmaceutical company, launched Soliqua, a once-daily fixed-ratio combination of insulin glargine and lixisenatide specifically designed for adults with type 2 diabetes and obesity. Soliqua combines long-acting insulin glargine, which provides steady fasting glucose control, with lixisenatide, a GLP-1 receptor agonist. This combination enhances glucose-dependent insulin secretion, suppresses glucagon production, and slows gastric emptying to reduce post-meal blood sugar levels, thereby offering comprehensive daily glycemic management. The launch of Soliqua aims to simplify diabetes management, improve glycemic control, and enhance patient adherence by decreasing the need for multiple daily injections and minimizing potential side effects such as hypoglycemia and weight gain.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Diabetes Care Drugs Market? Lupin Secures SGLT-2 Trademarks From Boehringer Ingelheim

In December 2024, Lupin Limited, an India-based pharmaceutical company, acquired anti-diabetes trademarks from Boehringer Ingelheim International GmbH for an undisclosed amount. With this acquisition, Lupin holds full trademark rights to GIBTULIO, GIBTULIO MET, and AJADUO, enabling the company to fully integrate and independently market these oral antidiabetic products across India, thereby consolidating and expanding its diabetes care portfolio. Boehringer Ingelheim International GmbH is a Germany-based pharmaceutical company that specializes in manufacturing diabetes care drugs.

What Is The Regional Outlook For The Global Diabetes Care Drugs Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Diabetes Care Drugs Industry?

The diabetes care drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including the diabetes care drugs industry's global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care drugs market. This diabetes care drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Diabetes Care Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$73.48 billion
Revenue Forecast In 2034	$90.50 billion
Growth Rate	CAGR of 5.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Drug Class, Formulation Type, Administration Route, Condition, Distribution Channel, Insulin, Biguanides, Sulfonylureas, Dipeptidyl Peptidase (DPP)-4 Inhibitors, Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, Glucagon-Like Peptide (GLP)-1 Receptor Ago
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GSK plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceuticals Limited, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Takeda Pharmaceutical Company Limited, Biocon Limited, Glenmark Pharmaceuticals Limited, Insulet Corporation, Torrent Pharmaceuticals Ltd., Hanmi Pharmaceutical Limited, Hualan Biological, Wockhardt, Mitsubishi Tanabe Pharma, Gan & Lee Pharmaceuticals, DiogenX, Oramed Pharmaceuticals, Apotex.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Diabetes Care Drugs Market Characteristics

3. Diabetes Care Drugs Market Trends And Strategies

4. Diabetes Care Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Care Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Diabetes Care Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Diabetes Care Drugs Market Growth Rate Analysis

5.4. Global Diabetes Care Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Diabetes Care Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Diabetes Care Drugs Total Addressable Market (TAM)

6. Diabetes Care Drugs Market Segmentation

6.1. Global Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insulin

Biguanides

Sulfonylureas

Dipeptidyl Peptidase (DPP)-4 Inhibitors

Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors

Glucagon-Like Peptide (GLP)-1 Receptor Agonists

Thiazolidinediones

Alpha-Glucosidase Inhibitors

6.2. Global Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Injections

Solutions

Gels

Extended-Release Formulations

6.3. Global Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

Inhalable

6.4. Global Diabetes Care Drugs Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diabetes Type 1

Diabetes Type 2

6.5. Global Diabetes Care Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Specialty Pharmacies

6.6. Global Diabetes Care Drugs Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rapid-acting insulin

Short-acting insulin

Intermediate-acting insulin

Long-acting insulin

Pre-mixed insulin

6.7. Global Diabetes Care Drugs Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metformin Immediate Release (IR)

Metformin Extended Release (ER)

6.8. Global Diabetes Care Drugs Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

First-generation sulfonylureas

Second-generation sulfonylureas

6.9. Global Diabetes Care Drugs Market, Sub-Segmentation Of Dipeptidyl Peptidase (DPP)-4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sitagliptin

Saxagliptin

Linagliptin

Alogliptin

6.10. Global Diabetes Care Drugs Market, Sub-Segmentation Of Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Canagliflozin

Dapagliflozin

Empagliflozin

Ertugliflozin

6.11. Global Diabetes Care Drugs Market, Sub-Segmentation Of Glucagon-Like Peptide (GLP)-1 Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Exenatide

Liraglutide

Dulaglutide

Semaglutide

Lixisenatide

6.12. Global Diabetes Care Drugs Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pioglitazone

Rosiglitazone

6.13. Global Diabetes Care Drugs Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acarbose

Miglitol

7. Diabetes Care Drugs Market Regional And Country Analysis

7.1. Global Diabetes Care Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Diabetes Care Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Care Drugs Market

8.1. Asia-Pacific Diabetes Care Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Care Drugs Market

9.1. China Diabetes Care Drugs Market Overview

9.2. China Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Care Drugs Market

10.1. India Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Care Drugs Market

11.1. Japan Diabetes Care Drugs Market Overview

11.2. Japan Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Care Drugs Market

12.1. Australia Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Care Drugs Market

13.1. Indonesia Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Care Drugs Market

14.1. South Korea Diabetes Care Drugs Market Overview

14.2. South Korea Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Care Drugs Market

15.1. Western Europe Diabetes Care Drugs Market Overview

15.2. Western Europe Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Care Drugs Market

16.1. UK Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Care Drugs Market

17.1. Germany Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Care Drugs Market

18.1. France Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Care Drugs Market

19.1. Italy Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Care Drugs Market

20.1. Spain Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Care Drugs Market

21.1. Eastern Europe Diabetes Care Drugs Market Overview

21.2. Eastern Europe Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Care Drugs Market

22.1. Russia Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Care Drugs Market

23.1. North America Diabetes Care Drugs Market Overview

23.2. North America Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Care Drugs Market

24.1. USA Diabetes Care Drugs Market Overview

24.2. USA Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Care Drugs Market

25.1. Canada Diabetes Care Drugs Market Overview

25.2. Canada Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Care Drugs Market

26.1. South America Diabetes Care Drugs Market Overview

26.2. South America Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Care Drugs Market

27.1. Brazil Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Care Drugs Market

28.1. Middle East Diabetes Care Drugs Market Overview

28.2. Middle East Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Care Drugs Market

29.1. Africa Diabetes Care Drugs Market Overview

29.2. Africa Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Care Drugs Market Competitive Landscape And Company Profiles

30.1. Diabetes Care Drugs Market Competitive Landscape

30.2. Diabetes Care Drugs Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Care Drugs Market Other Major And Innovative Companies

31.1. AstraZeneca plc

31.2. Abbott Laboratories

31.3. GSK plc

31.4. Medtronic plc

31.5. Eli Lilly and Company

31.6. Teva Pharmaceuticals Limited

31.7. Astellas Pharma Inc.

31.8. Sun Pharmaceutical Industries Ltd.

31.9. Aurobindo Pharma Limited

31.10. Dr. Reddy's Laboratories

31.11. Cipla Limited

31.12. Lupin Limited

31.13. Takeda Pharmaceutical Company Limited

31.14. Biocon Limited

31.15. Glenmark Pharmaceuticals Limited

32. Global Diabetes Care Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Care Drugs Market

34. Recent Developments In The Diabetes Care Drugs Market

35. Diabetes Care Drugs Market High Potential Countries, Segments and Strategies

35.1 Diabetes Care Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Diabetes Care Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Diabetes Care Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Diabetes Care Drugs Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Diabetes Care Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Diabetes Care Drugs Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Diabetes Care Drugs Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Diabetes Care Drugs Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Diabetes Care Drugs Market, Sub-Segmentation Of Dipeptidyl Peptidase (DPP)-4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Diabetes Care Drugs Market, Sub-Segmentation Of Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Diabetes Care Drugs Market, Sub-Segmentation Of Glucagon-Like Peptide (GLP)-1 Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Diabetes Care Drugs Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Diabetes Care Drugs Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Global Diabetes Care Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Global Diabetes Care Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: China, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: China, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: India, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: India, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Japan, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Japan, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Australia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Australia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Indonesia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Indonesia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: South Korea, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: South Korea, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Western Europe, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Western Europe, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: UK, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: UK, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Germany, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Germany, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: France, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: France, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Italy, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Italy, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Spain, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Spain, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Russia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Russia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: North America, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: North America, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: USA, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: USA, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Canada, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Canada, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: South America, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: South America, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Brazil, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Brazil, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Middle East, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Middle East, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Africa, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 83: Africa, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 84: Johnson & Johnson Financial Performance

Table 85: Merck & Co. Inc. Financial Performance

Table 86: Bayer AG Financial Performance

Table 87: Sanofi S.A. Financial Performance

Table 88: Bristol-Myers Squibb Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Diabetes Care Drugs Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Diabetes Care Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Diabetes Care Drugs Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Diabetes Care Drugs Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Diabetes Care Drugs Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Diabetes Care Drugs Market, Sub-Segmentation Of Dipeptidyl Peptidase (DPP)-4 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Diabetes Care Drugs Market, Sub-Segmentation Of Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Diabetes Care Drugs Market, Sub-Segmentation Of Glucagon-Like Peptide (GLP)-1 Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Diabetes Care Drugs Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Diabetes Care Drugs Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Global Diabetes Care Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Global Diabetes Care Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Asia-Pacific, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: China, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: China, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: India, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: India, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Japan, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Japan, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Australia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Australia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Indonesia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Indonesia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: South Korea, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: South Korea, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Western Europe, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Western Europe, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: UK, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: UK, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Germany, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Germany, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: France, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: France, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Italy, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Italy, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Spain, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Spain, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Eastern Europe, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Russia, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Russia, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: North America, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: North America, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: USA, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: USA, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Canada, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Canada, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: South America, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: South America, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Brazil, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Brazil, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Middle East, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Middle East, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Diabetes Care Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Africa, Diabetes Care Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 83: Africa, Diabetes Care Drugs Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 84: Johnson & Johnson Financial Performance

Figure 85: Merck & Co. Inc. Financial Performance

Figure 86: Bayer AG Financial Performance

Figure 87: Sanofi S.A. Financial Performance

Figure 88: Bristol-Myers Squibb Company Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Diabetes Care Devices Market 2022 - By Type (Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, Insulin Pens, Syringes, Pumps And Injectors), By Type Of Expenditure (Public, Private), By E...

Antidiabetics Global Market Report 2025 – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes,), By Diabetes Type (Type 1, Type 2), By Patient Population (Antidiabetic...

Non-Insulin Therapies For Diabetes Global Market Report 2025 – By Drug Class (Biguanides, Sulfonylureas, Thiazolidinedione’s, Alpha-Glucosidase Inhibitors, Dipeptidyl peptidase-4 (DPP-, Inhibitors, Glucagon-like peptide-...

Clinical Nutrition For Diabetes Care Global Market Report 2025 – By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Institutional S...

Pet Diabetes Care Global Market Report 2025 – By Drug Type( Insulin Therapy, Oral Medication ), By Device Type( Glucose Monitoring Devices, Insulin Delivery Devices ), By Animal Type( Canine, Feline, Other Animal Types )...

Antidiabetics Global Market Report 2025 – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes,), By Diabetes Type (Type 1, Type 2), By Patient Population (Antidiabetic...

Frequently Asked Questions

What is the definition of the Diabetes Care Drugs market?

Diabetes care drugs are medications used to manage blood glucose levels in individuals with diabetes mellitus, including type 1, type 2, and gestational diabetes. These drugs work by improving insulin production, enhancing insulin sensitivity, or reducing glucose absorption. The main aim of these drugs is to prevent complications by maintaining healthy blood sugar levels. For further insights on the Diabetes Care Drugs market, request a sample here

How will the Diabetes Care Drugs market drivers and restraints affect the market dynamics? What forces will shape the Diabetes Care Drugs industry going forward?

The Diabetes Care Drugs market major growth driver - Increasing Number Of Diabetic Patients Fueling The Growth Of The Market Due To Unhealthy Diets And Sedentary Lifestyles. For further insights on the Diabetes Care Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Diabetes Care Drugs market?

The Diabetes Care Drugs market size has grown strongly in recent years. The diabetes care drugs market size has grown strongly in recent years. It will grow from $69.55 billion in 2024 to $73.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising global prevalence of diabetes, increasing aging population, sedentary lifestyles and poor dietary habits, rising obesity rates, and growing adoption of personalized medicine. The diabetes care drugs market size is expected to see strong growth in the next few years. It will grow to $90.50 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to emergence of biosimilar insulins, development of combination therapies and fixed‑dose formulations, increasing focus on continuous glucose monitoring and closed‑loop systems, and rising awareness and prevention programs targeting prediabetes. Major trends in the forecast period include integration of continuous glucose monitoring with smart drug delivery, adoption of digital patient engagement platforms, wearable drug delivery devices, advancement in peptide or polymer-based sustained-release formulations, and integration of pharmacogenomics for personalized dosing. For further insights on the Diabetes Care Drugs market, request a sample here

How is the Diabetes Care Drugs market segmented?

The diabetes care drugs market covered in this report is segmented –
1) By Drug Class: Insulin, Biguanides, Sulfonylureas, Dipeptidyl Peptidase (DPP)-4 Inhibitors, Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, Glucagon-Like Peptide (GLP)-1 Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors
2) By Formulation Type: Tablets, Injections, Solutions, Gels, Extended-Release Formulations
3) By Administration Route: Oral, Injectable, Inhalable
4) By Condition: Diabetes Type 1, Diabetes Type 2
5) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies Subsegments:
1) By Insulin: Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, Long-acting insulin, Pre-mixed insulin
2) By Biguanides: Metformin Immediate Release (IR), Metformin Extended Release (ER)
3) By Sulfonylureas: First-generation sulfonylureas, Second-generation sulfonylureas
4) By Dipeptidyl Peptidase (DPP)-4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
5) By Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin
6) By Glucagon-Like Peptide (GLP)-1 Receptor Agonists: Exenatide, Liraglutide, Dulaglutide, Semaglutide, Lixisenatide
7) By Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone
8) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol For further insights on the Diabetes Care Drugs market, request a sample here

Which region has the largest share of the Diabetes Care Drugs market? What are the other regions covered in the report?

North America was the largest region in the diabetes care drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Diabetes Care Drugs market, request a sample here.

Who are the major players in the Diabetes Care Drugs market?

Major companies operating in the diabetes care drugs market are Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol‑Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GSK plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceuticals Limited, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Takeda Pharmaceutical Company Limited, Biocon Limited, Glenmark Pharmaceuticals Limited, Insulet Corporation, Torrent Pharmaceuticals Ltd., Hanmi Pharmaceutical Limited, Hualan Biological, Wockhardt, Mitsubishi Tanabe Pharma, Gan & Lee Pharmaceuticals, DiogenX, Oramed Pharmaceuticals, Apotex. . For further insights on the Diabetes Care Drugs market, request a sample here.

What are the key trends in the Diabetes Care Drugs market?

Major trends in the Diabetes Care Drugs market include Dual Action Therapy Controls Fasting And Post Meal Glucose Spikes. For further insights on the Diabetes Care Drugs market, request a sample here.